Mike Dooley, Co-founder and CEO of Labrador Systems, joins Cheddar News to discuss the company's 'Labrador Retriever' personal robot, aiming to support caregivers and help people with health issues live independently.
Share:
More In Technology
Between Social Media and Ozempic, Health Culture Is Totally Changing
There's so much dieting and nutrition advice just a swipe away. But experts say you shouldn't trust everything you see on your 'For You' page.
Years After the COVID-19 Pandemic, Respiratory Diseases Remain a Risk
Qiagen’s CEO shares the company’s plans for profitability and innovations in the world of disease testing.
Apple Intelligence Will Introduce the World to A.I.
Wired writer Brenda Stolyar breaks down the updates you may have missed from Apple’s WWDC. Plus, why when Apple does something, it ‘hits harder.’
Hybrid Vehicle Sales Surge in 2023, Outpacing EV Growth in Early 2024
In 2023, hybrid vehicle sales rose by 53%, making up 9% of new car sales. EV sales grew by 35% in 2023 but only 7% in Q1 2024. What's driving this trend?
Hey Siri: Tell Me What to Expect From Apple’s Developers Conference
Siri updates, new iPhones, and a whole lot of artificial intelligence – here’s a breakdown ahead of Apple’s Worldwide Developers Conference.
F45 CEO Talks Future Of Training, HYROX Partnership
F45 CEO Tom Dowd talks new parternship with fitness race company HYROX, his outlook on Ozempic, and new innovations in the workout space.
Would You Trust A.I. to Manage Your Money?
Northwestern Mutual’s A.I. and money report shows that consumers want their adviser to take advantage of ‘superpowers’ granted by artificial intelligence tools.
Casinos Are Rolling The Dice And Betting On The Big Apple
In 2022, New York approved legislation to allow three new full-scale casino licenses for the downstate region, including New York City.
Perspective Therapeutics Is Creating New Ways to Fight Cancer
In honor of National Cancer Research Month, Perspective Therapeutics discusses its latest treatment — currently in clinical trials — that targets cancer cells d
